Cancer Center Researchers Honored

Two researchers at the UW Carbone Cancer Center (UWCCC) were named 2010 Young Investigators by the Prostate Cancer Foundation. Joshua Lang and Justine Bruce were awarded three-year grants to continue their research projects on prostate cancer treatments.

Lang, a research fellow, is investigating a prostate cancer vaccine for patients with advanced disease. He will study medications that could attack the body’s immune system to attack tumor cells.

Bruce, assistant professor, Hematology-Oncology, School of Medicine and Public Health, will develop additional imaging techniques and new medicines for patients who do not show evidence of metastatic disease but whose prostate-specific antigen continues to increase after hormonal treatment. She is working with a novel experimental agent that inhibits tumor growth and disease progression.

Lang and Bruce are among a select group of investigators and research fellows from distinguished academic medical centers including Memorial Sloan-Kettering in New York City and the M.D. Anderson Cancer Center and the University of Texas to receive the Young Investigators honor.

The UWCCC is a founding member of the Prostate Cancer Clinical Trials Consortium with the U.S. Department of Defense. The consortium represents the most active prostate cancer clinical research sites in the world.